Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-008342
Filing Date
2025-03-05
Accepted
2025-03-05 17:03:51
Documents
2
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6632
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 3392
  Complete submission text file 0001127602-25-008342.txt   11468
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
Eckert Celia (Reporting) CIK: 0001787397 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36182 | Film No.: 25712270